• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

NeuroFlow, Novant Health Partner to Extend Mental Health Offerings.

Share:

July 17, 2023

Novant Health, based in Winston-Salem, North Carolina, is collaborating with behavioral health company NeuroFlow to expand mental health services for patients and team members. Through NeuroFlow’s cloud-based platform, patients will have continuous access to mental health resources, and Novant’s physicians can monitor their progress and provide support. NeuroFlow’s AI-driven clinical decision support and digital tools will aid in tracking, assessing, and connecting with patients. The partnership aligns with Novant’s commitment to enhancing mental and behavioral health care for its community. NeuroFlow has previously secured funding and formed partnerships to advance collaborative care models and suicide prevention programs.

Winston-Salem, North Carolina-based healthcare provider Novant Health is partnering with Pennsylvania-based behavioral health company NeuroFlow to provide extended mental health services to its patients and team members.

NeuroFlow’s cloud-based platform allows healthcare providers to track, assess and connect with patients between traditional office visits. The company also offers AI-driven clinical decision support with individualized recommendations for next steps for patients, educational content, mood and sleep logs, journaling capabilities, and wellbeing screenings.

Through the partnership, Novant patients 13 years or older with depression will have access to NeuroFlow’s mental health resources and support around the clock. Novant’s team members will also be able to access NeuroFlow’s offerings for self-care management.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“Our partnership with NeuroFlow gives patients grappling with mental and behavioral health needs continuous access to a digital toolbox, and – most importantly – they can be monitored by a Novant Health physician who can provide additional support and intervention,” Dr. Ashley Perrott, senior physician executive for Novant Health’s Community Health and Wellness Institute, said in a statement.

THE LARGER TREND

NeuroFlow scored $7.5 million in Series A funding in 2019 and $20 million in Series B in 2021. Last year, the company secured a $25 million investment.

In February, the company was one of ten digital care companies to win the Veterans Affairs’ Mission Daybreak Grand Challenge, which is part of a 10-year strategy to end veteran suicide through a comprehensive public health approach.

In May, the company announced a partnership with Georgia-based Emory Healthcare to scale the healthcare system’s collaborative care model to increase access to behavioral health services and pilot a primary care suicide prevention program.

NeuroFlow also partnered with New Jersey-based Atlantic Health System to advance a collaborative care model for adult behavioral health patients at 16 accountable care organization (ACO) sites.

In December, Novant Health announced it was partnering with Movano Health to beta test the “functionality and wearability” of its smart rings with 30 of the health system’s employees.

Source: MobihealthNews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • BioArctic’s partner Eisai initiates BLA submission of data for lecanemab in ChinaBioArctic’s partner Eisai initiates BLA submission of data for lecanemab in China
  • ACADIA Pharmaceuticals Acquires CerSci Therapeutics, Adds Novel Pain Program to PortfolioACADIA Pharmaceuticals Acquires CerSci Therapeutics, Adds Novel Pain Program to Portfolio
  • Alibaba Fund backs Hong Kong-based health monitoring firm PanopticAIAlibaba Fund backs Hong Kong-based health monitoring firm PanopticAI
  • COVID-19 pandemic – Oncology Cytotoxic Drug Market Research Outlook, Recent Trends and Growth Forecast 2020-2025COVID-19 pandemic – Oncology Cytotoxic Drug Market Research Outlook, Recent Trends and Growth Forecast 2020-2025
  • Sound United Enters Into Agreement to be Acquired By Masimo CorporationSound United Enters Into Agreement to be Acquired By Masimo Corporation
  • Pear’s Somryst Precursor Improved Sleep Health Measures Among Patients with Chronic Insomnia and Depressive SymptomsPear’s Somryst Precursor Improved Sleep Health Measures Among Patients with Chronic Insomnia and Depressive Symptoms
  • Super-Spreading of COVID-19 Co-Infections Reveals a Deadly Diagnostics GapSuper-Spreading of COVID-19 Co-Infections Reveals a Deadly Diagnostics Gap
  • Treprostinil Drugs Market – Insights on how Players Have Cemented Their Positions with Disruptive Technologies, Key Players are United Therapeutics, Novartis, and Teva Pharmaceutical Industries LtdTreprostinil Drugs Market – Insights on how Players Have Cemented Their Positions with Disruptive Technologies, Key Players are United Therapeutics, Novartis, and Teva Pharmaceutical Industries Ltd

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications